NPR's Noel King talks to Paul Offit of the Vaccine Education Center at Children's Hospital of Philadelphia, about the coronavirus vaccine trial developed by AstraZeneca and the University of Oxford.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump's warp speed COVID vaccine plan hits snag as AstraZeneca pauses trialPhase 3 trials for AstraZeneca's COVID-19 vaccine candidate were paused Tuesday due to a 'potentially unexplained illness in one of the trials.'
Read more »
AstraZeneca Pauses Covid-19 Vaccine Trial After Illness in a U.K. SubjectAstraZeneca said it paused clinical trials of an experimental Covid-19 vaccine after a participant in a U.K. study had an unexplained illness.
Read more »
COVID-19 Vaccine Trial Paused, Due To Illness In One VolunteerDrugmaker AstraZeneca says it's pausing its COVID-19 vaccine trial because of a 'potentially unexplained illness' in one of the trial volunteers. A safety review will be conducted to determine if it's a chance event or somehow related to the vaccine.
Read more »
AstraZeneca COVID-19 vaccine tests paused after participant becomes illStudies of AstraZeneca’s COVID-19 vaccine candidate are on hold while the company investigates whether a recipient’s illness is a side effect of the shot.
Read more »
AstraZeneca's Covid-19 vaccine trial suspended after volunteer falls illAstraZeneca’s Covid-19 vaccine candidate is on temporary hold to investigate whether a recipient’s “potentially unexplained” illness is a side effect of the shot.
Read more »
AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illnessAstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
Read more »